Considerations in antithrombotic therapy among patients undergoing transcatheter aortic valve implantation

@article{Lynch2013ConsiderationsIA,
  title={Considerations in antithrombotic therapy among patients undergoing transcatheter aortic valve implantation},
  author={Donald R. Lynch and David M Dantzler and Mark Robbins and David Zhao},
  journal={Journal of Thrombosis and Thrombolysis},
  year={2013},
  volume={35},
  pages={476-482}
}
Aortic stenosis (AS) accounts for the majority of valvular abnormalities requiring surgical intervention. Platelet dysfunction has been demonstrated among patients with severe aortic stenosis which may predispose patients to bleeding or ischemic events. Surgical aortic valve replacement (AVR) is the standard therapy for severe symptomatic AS; however, a number of patients have very high or prohibitive surgical risk. Transcatheter aortic valve implantation (TAVI) has been shown to be superior to… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Antithrombotic therapy in TAVI

Journal of geriatric cardiology : JGC • 2018

Upper gastrointestinal bleeding following transcatheter aortic valve replacement: A retrospective analysis.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions • 2017
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 22 references

A prospective, randomized trial of single vs. dual anti-platelet therapy after transcatheter aortic valve replacement in high-risk patients with aortic stenosis

ESG Stabile, A Pucciarelli, L Cota, eds et al
SAT-TAVI • 2011
View 1 Excerpt

Antithrombotic therapy after bioprosthetic aortic valve replacement: ACTION Registry survey results.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery • 2008
View 1 Excerpt

Similar Papers

Loading similar papers…